MarketCap
Facebook
X
TelegramGeschäftsbericht 2023
hinzugefügt 29.02.2024
PetIQ Kurzfristige Verbindlichkeiten 2011-2025 | PETQ
Kurzfristige Verbindlichkeiten Jährlich PetIQ
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 190 M | 149 M | 98.1 M | 101 M | 73 M | 64.2 M | 18.2 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 190 M | 18.2 M | 99.1 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Arzneimittelhersteller
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Canopy Growth Corporation
CGC
|
94.4 M | $ 1.74 | - | $ 187 M |  Canada |
 |
Alimera Sciences
ALIM
|
21.9 M | - | - | $ 142 M |  USA |
 |
Assertio Holdings
ASRT
|
93.4 M | $ 0.76 | - | $ 54 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
125 M | - | - | $ 754 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
2.65 M | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
11.4 M | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
20.8 M | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
1.03 B | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
27 M | - | - | $ 50.1 M | USA |
 |
Organogenesis Holdings
ORGO
|
77.5 M | $ 4.82 | - | $ 635 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
111 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
539 M | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
651 M | $ 11.41 | - | $ 584 M | USA |
 |
Pacira BioSciences
PCRX
|
310 M | $ 26.29 | - | $ 1.22 B | USA |
 |
Evoke Pharma
EVOK
|
9.65 M | $ 10.95 | - | $ 36.6 M | USA |
 |
Athenex
ATNX
|
115 M | - | -23.39 % | $ 1.76 M | USA |
 |
Rockwell Medical
RMTI
|
16.6 M | $ 0.92 | - | $ 21.5 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
48.8 M | $ 21.36 | - | $ 2.03 B |  France |
 |
Solid Biosciences
SLDB
|
30.3 M | $ 5.87 | - | $ 240 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
4.1 M | $ 3.59 | - | $ 4.46 M | USA |
 |
Evolus
EOLS
|
63 M | $ 7.04 | 1.88 % | $ 437 M | USA |
 |
Harrow Health
HROW
|
49.3 M | $ 47.06 | - | $ 1.53 B | USA |
 |
China Pharma Holdings
CPHI
|
5.02 M | $ 1.55 | -0.38 % | $ 27.1 M |  China |
 |
Veru
VERU
|
11.9 M | $ 2.42 | - | $ 326 M | USA |
 |
Bausch Health Companies
BHC
|
4.3 B | $ 6.92 | - | $ 2.53 B | Canada |
 |
Lannett Company
LCI
|
105 M | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
31.6 M | $ 2.53 | 1.61 % | $ 35.6 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
23 M | - | - | $ 193 M | Canada |
 |
Relmada Therapeutics
RLMD
|
12.2 M | $ 4.06 | - | $ 122 M | USA |
 |
Jupiter Wellness
JUPW
|
9.4 M | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
1.04 B | $ 13.14 | - | $ 1.81 B | USA |
 |
ProPhase Labs
PRPH
|
16.1 M | $ 0.11 | - | $ 1.74 M | USA |
 |
Radius Health
RDUS
|
94.8 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
50 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
177 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
11.9 M | - | -27.8 % | $ 2.56 M | USA |
 |
cbdMD
YCBD
|
8.62 M | $ 1.2 | - | $ 5.18 M | USA |
 |
SCYNEXIS
SCYX
|
16.3 M | $ 0.65 | - | $ 31.1 M | USA |
 |
Tricida
TCDA
|
29.5 M | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
433 M | $ 12.15 | - | $ 7.51 B | Canada |
 |
TherapeuticsMD
TXMD
|
6.85 M | $ 1.75 | - | $ 18.3 M | USA |
 |
Zomedica Corp.
ZOM
|
9.03 M | - | -0.21 % | $ 98 M | USA |
 |
Viatris
VTRS
|
6.75 B | $ 11.65 | - | $ 14.1 B | USA |